ICAM1 and cancer: The inoculation of tumorous cells, in our in vivo cancer model, causes the recruitment of tissue-resident macrophages and other circulating inflammatory mediators to the invasion site, finally leading to a decrease in ICAM−1's production (cf. different responses in mammalian cell lines) [[18], [19], [20]].